Vault-13

CHI Advisors LLC

NEW YORK, NY · CIK 1791468 · 13F filing filed 2023-11-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$252.1m reported value -23.5% vs Q2 2023
26positions
81.4%in top 10
4 new 8 added 8 reduced 3 sold out vs Q2 2023

Options: 2 call positions ($212.5k notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q3 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 PLIANT THERAPEUTICS INC COM PLRX PLRX 3,014,199 $52.3m20.73% 20.73% ReducedShares held: Q4 2022 3.2m, Q1 2023 3.0m, Q2 2023 3.1m, Q3 2023 3.0m -102.8k -102,818 -3.3%
2 REPARE THERAPEUTICS INC COM RPTX RPTX 2,966,674 $35.8m14.22% 14.22% ReducedShares held: Q4 2022 2.8m, Q1 2023 3.0m, Q2 2023 3.0m, Q3 2023 3.0m -32.1k -32,060 -1.1%
3 CULLINAN THERAPEUTICS INC COM CGEM CGEM 3,414,189 $30.9m12.26% 12.26% UnchangedShares held: Q4 2022 3.3m, Q1 2023 3.3m, Q2 2023 3.4m, Q3 2023 3.4m
4 ACELYRIN INC COM COM 2,262,990 $23.0m9.13% 9.13% ReducedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 2.7m, Q3 2023 2.3m -400.8k -400,816 -15.1%
5 ORCHARD THERAPEUTICS PLC SPON ADS NEW SPON ADS NEW 12,315,654 $14.0m5.57% 5.57% AddedShares held: Q4 2022 0, Q1 2023 785.7k, Q2 2023 755.7k, Q3 2023 12.3m +11.6m +11,559,916 1529.6%
6 LARIMAR THERAPEUTICS INC COM LRMR LRMR 3,414,468 $13.5m5.35% 5.35% UnchangedShares held: Q4 2022 3.5m, Q1 2023 2.7m, Q2 2023 3.4m, Q3 2023 3.4m
7 KEROS THERAPEUTICS INC COM KROS KROS 407,633 $13.0m5.15% 5.15% AddedShares held: Q4 2022 215.1k, Q1 2023 261.1k, Q2 2023 402.1k, Q3 2023 407.6k +5.5k +5,515 1.4%
8 IKENA ONCOLOGY INC COM COM 2,180,934 $9.4m3.75% 3.75% AddedShares held: Q4 2022 1.6m, Q1 2023 1.7m, Q2 2023 2.1m, Q3 2023 2.2m +58.9k +58,894 2.8%
9 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 215,000 $7.7m3.04% 3.04% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 85.0k, Q3 2023 215.0k +130.0k +130,000 152.9%
10 COMPASS THERAPEUTICS INC COM CMPX CMPX 2,829,712 $5.6m2.21% 2.21% UnchangedShares held: Q4 2022 2.8m, Q1 2023 2.8m, Q2 2023 2.8m, Q3 2023 2.8m
11 MINERALYS THERAPEUTICS INC COM MLYS MLYS 568,379 $5.4m2.14% 2.14% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 568.4k
12 INOZYME PHARMA INC COM COM 1,270,027 $5.3m2.12% 2.12% AddedShares held: Q4 2022 2.2m, Q1 2023 1.3m, Q2 2023 1.2m, Q3 2023 1.3m +75.0k +75,000 6.3%
13 SYROS PHARMACEUTICALS INC COM NEW SYRS SYRS 1,299,359 $5.1m2.03% 2.03% AddedShares held: Q4 2022 0, Q1 2023 767.4k, Q2 2023 767.4k, Q3 2023 1.3m +531.9k +531,914 69.3%
14 BLUEPRINT MEDICINES CORP COM BPMC BPMC 92,888 $4.7m1.85% 1.85% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 92.9k
15 DIREXION SHS ETF TR DAILY S&P BIOTEC LABD LABD 225,000 $4.6m1.84% 1.84% ReducedShares held: Q4 2022 25.0k, Q1 2023 0, Q2 2023 325.0k, Q3 2023 225.0k -100.0k -100,000 -30.8%
16 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 1,002,007 $3.9m1.56% 1.56% AddedShares held: Q4 2022 333.3k, Q1 2023 855.0k, Q2 2023 852.0k, Q3 2023 1.0m +150.0k +150,000 17.6%
17 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 60,000 $3.4m1.36% 1.36% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 60.0k
18 OVID THERAPEUTICS INC COM OVID OVID 864,822 $3.3m1.32% 1.32% UnchangedShares held: Q4 2022 864.8k, Q1 2023 864.8k, Q2 2023 864.8k, Q3 2023 864.8k
19 SAGIMET BIOSCIENCES INC COM SER A SGMT SGMT 348,842 $3.1m1.22% 1.22% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 348.8k
20 OMEGA THERAPEUTICS INC COMMON STOCK COMMON STOCK 1,055,882 $2.3m0.90% 0.90% UnchangedShares held: Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m, Q3 2023 1.1m
21 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 720,000 $2.1m0.82% 0.82% ReducedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 750.0k, Q3 2023 720.0k -30.0k -30,000 -4.0%
22 RALLYBIO CORP COM COM 390,734 $1.3m0.52% 0.52% ReducedShares held: Q4 2022 726.1k, Q1 2023 760.5k, Q2 2023 542.8k, Q3 2023 390.7k -152.0k -152,040 -28.0%
23 DISC MEDICINE INC COM IRON IRON 25,000 $1.2m0.47% 0.47% ReducedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 125.1k, Q3 2023 25.0k -100.1k -100,139 -80.0%
24 GRAPHITE BIO INC COM GRPH GRPH 230,938 $572.7k0.23% 0.23% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 230.9k, Q3 2023 230.9k
25 FREELINE THERAPEUTICS HLDGS SPONSORED ADS SPONSORED ADS 86,654 $372.6k0.15% 0.15% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 21.7k, Q3 2023 86.7k +65.0k +64,988 299.9%
26 PRECISION BIOSCIENCES INC COM COM 606,629 $207.0k0.08% 0.08% ReducedShares held: Q4 2022 3.5m, Q1 2023 3.5m, Q2 2023 1.6m, Q3 2023 606.6k -996.9k -996,928 -62.2%

Sold out since Q2 2023

SecurityTickerShares held beforeValue then
VECTIVBIO HLDG AG 2,782,756 $46.9m2.8m shares
HOOKIPA PHARMA INC 788,740 $694.1k788.7k shares
CORVUS PHARMACEUTICALS INC CRVS CRVS 200,000 $458.0k200.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
REPARE THERAPEUTICS INC RPTX · Call RPTXCall 50,000 $157.5k50.0k shares New
PLIANT THERAPEUTICS INC PLRX · Call PLRXCall 137,500 $55.0k137.5k shares Added